Quantitative Proteomics of Hepatic Drug‐Metabolizing Enzymes and Transporters in Patients With Colorectal Cancer Metastasis-Reference-Cited by-同舟云学术

Quantitative Proteomics of Hepatic Drug‐Metabolizing Enzymes and Transporters in Patients With Colorectal Cancer Metastasis

Author:

Vasilogianni Areti‐Maria¹,Al‐Majdoub Zubida M.¹,Achour Brahim¹²,Annie Peters Sheila³,Barber Jill¹,Rostami‐Hodjegan Amin¹⁴

Affiliation:

1. Centre for Applied Pharmacokinetic Research Division of Pharmacy and Optometry School of Health Sciences University of Manchester Manchester UK

2. Department of Biomedical and Pharmaceutical Sciences College of Pharmacy University of Rhode Island Kingston Rhode Island USA

3. Translational Quantitative Pharmacology BioPharma R&D Global Early Development Merck KGaA Darmstadt Germany

4. Certara Inc. (Simcyp Division) Sheffield UK

Funder

Merck KGaA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

Reference45 articles.

4. Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients (review);Nikolouzakis T.;Oncol. Rep.,2018

5. Literature review of current management of colorectal liver metastasis;Mitchell D.;Cureus,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献